4.0(top 10%)
impact factor
606(top 50%)
papers
19.7K(top 10%)
citations
63(top 10%)
h-index
4.2(top 10%)
impact factor
671
all documents
21.0K
doc citations
116(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Lead- and drug-like compounds: the rule-of-five revolutionDrug Discovery Today: Technologies20043,723
2PROteolysis TArgeting Chimeras (PROTACs) — Past, present and futureDrug Discovery Today: Technologies2019458
3The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rateDrug Discovery Today: Technologies2012436
4Scaffold hoppingDrug Discovery Today: Technologies2004296
5The production of 3D tumor spheroids for cancer drug discoveryDrug Discovery Today: Technologies2017283
6Vesicles as a tool for transdermal and dermal deliveryDrug Discovery Today: Technologies2005259
7Nanoparticle uptake by the oral route: Fulfilling its potential?Drug Discovery Today: Technologies2005212
8Clinical trials for BET inhibitors run ahead of the scienceDrug Discovery Today: Technologies2016209
9‘In silico’ simulations to assess the ‘in vivo’ consequences of ‘in vitro’ metabolic drug–drug interactionsDrug Discovery Today: Technologies2004197
10Subcutaneous drug delivery and the role of the lymphaticsDrug Discovery Today: Technologies2005195
11A compact review of molecular property prediction with graph neural networksDrug Discovery Today: Technologies2020182
12Combination of ligand- and structure-based methods in virtual screeningDrug Discovery Today: Technologies2013170
13Ligand efficiency as a guide in fragment hit selection and optimizationDrug Discovery Today: Technologies2010167
14General principles of antibiotic resistance in bacteriaDrug Discovery Today: Technologies2014157
15In silico target fishing: Predicting biological targets from chemical structureDrug Discovery Today: Technologies2006155
16Prediction of blood–brain barrier permeation in drug discovery from in vivo, in vitro and in silico modelsDrug Discovery Today: Technologies2004151
17Multicomponent reactions – opportunities for the pharmaceutical industryDrug Discovery Today: Technologies2013149
18Overcoming poor oral bioavailability using nanoparticle formulations – opportunities and limitationsDrug Discovery Today: Technologies2012144
19Intracellular delivery of protein and peptide therapeuticsDrug Discovery Today: Technologies2008143
20Multi-objective optimization methods in drug designDrug Discovery Today: Technologies2013134
21Biofilms as a mechanism of bacterial resistanceDrug Discovery Today: Technologies2014130
22New trends in carbohydrate-based vaccinesDrug Discovery Today: Technologies2004123
23Buccal drug delivery: A challenge already won?Drug Discovery Today: Technologies2005121
24The controversial world of sirtuinsDrug Discovery Today: Technologies2014120
25Ultrasound-mediated drug delivery to the brain: principles, progress and prospectsDrug Discovery Today: Technologies2016120
26Translational pharmacokinetics and pharmacodynamics of monoclonal antibodiesDrug Discovery Today: Technologies2016117
27Advances in virtual screeningDrug Discovery Today: Technologies2006113
28SNIPERs—Hijacking IAP activity to induce protein degradationDrug Discovery Today: Technologies2019112
29Advances in screening for membrane permeability: high-resolution PAMPA for medicinal chemistsDrug Discovery Today: Technologies2004106
30Lipid-based formulations for oral delivery of lipophilic drugsDrug Discovery Today: Technologies2012106
31Chitosan and the mucosal delivery of biotechnology drugsDrug Discovery Today: Technologies2005105
32Mucoadhesive systems in oral drug deliveryDrug Discovery Today: Technologies2005103
33Smart polymeric micelles for gene and drug deliveryDrug Discovery Today: Technologies2005102
34Nanobodies – from llamas to therapeutic proteinsDrug Discovery Today: Technologies2010102
35Strategies for 3D pharmacophore-based virtual screeningDrug Discovery Today: Technologies201097
36Conformations and 3D pharmacophore searchingDrug Discovery Today: Technologies201095
37Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicityDrug Discovery Today: Technologies201395
38Small-molecule PROTAC degraders of the Bromodomain and Extra Terminal (BET) proteins — A reviewDrug Discovery Today: Technologies201992
39Scoring functions for protein–ligand interactions: a critical perspectiveDrug Discovery Today: Technologies200491
40Recent advances in CHO cell line development for recombinant protein productionDrug Discovery Today: Technologies202089
41Recombinant therapeutic protein production in cultivated mammalian cells: current status and future prospectsDrug Discovery Today: Technologies200888
42Lipophilicity – beyond octanol/water: a short comparison of modern technologiesDrug Discovery Today: Technologies200486
43New technologies in computer-aided drug design: Toward target identification and new chemical entity discoveryDrug Discovery Today: Technologies200685
44Physicochemical profiling: overview of the screensDrug Discovery Today: Technologies200483
45Drying methods for protein pharmaceuticalsDrug Discovery Today: Technologies200883
46Label-free receptor assaysDrug Discovery Today: Technologies201082
47Overcoming antifungal resistanceDrug Discovery Today: Technologies201480
48Cereblon modulators: Low molecular weight inducers of protein degradationDrug Discovery Today: Technologies201977
49Pharmacophore definition and 3D searchesDrug Discovery Today: Technologies200475
50Animal models of Alzheimer's disease and drug developmentDrug Discovery Today: Technologies201375